Rosy Hu (Morningside) joins Mesentech's board of directors

Rosy is a member of the investment team at Morningside. Previously, she was on the investment team at Mass General Brigham Ventures where she focused on company creation and led early-stage seed investments. Rosy was trained as a molecular biologist. She received her PhD from Harvard University and undergraduate degree from Queen’s University in Canada.